As of 10:30 AM on the 1st, Komipharm is trading at 17,650 KRW, up 3.22% from the previous day. This marks a 7.62% increase compared to June 15. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners are tentatively recorded as net buyers of 20,563 shares. Over the past five days, individual investors have net purchased 219,891 shares, while foreigners and institutions have net sold 230,991 shares and 2,035 shares, respectively.

On June 25, Komipharm became a market issue with the headline "Rise on COVID-19 Treatment Clinical Trial Application."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing